
For patients undergoing functional endoscopic sinus surgery (FESS) for chronic sinusitis, primarily for preventing post-FESS adhesions, maintaining nasal patency, and reducing inflammation.
Biodegradable: Naturally absorbs into the body over time,avoiding the need for a second removal procedure.
Drug-Eluting: Releases anti-inflammatory medicationdirectly to the target area, enhancing treatment efficacy.
Supports Healing: Maintains sinus patency while promotingtissue recovery and reducing scarring.
Minimally Invasive: Easy to implant, reducing patientdiscomfort and recovery time.
| Ref. NO. | SHAPE | Catalog Number | Diameter of Stent/mm | Height | Conveyor Angle | ||
| Top | Middle | Bottom | |||||
| 4014-1 | STRAIGHT(40) | OMNS-40404014-Z-1 | 40 | 40 | 40 | 14 | 10° |
| 4016-1 | QMNS-40404016-Z-1 | 16 | |||||
| 4018-1 | QMNS-40404018-Z-1 | 18 | |||||
| 4020-1 | QMNS-254016-T-Z-1 | 20 | |||||
| 4014-2 | QMNS-40404014-Z-2 | 40 | 40 | 40 | 14 | 70° | |
| 4016-2 | QMNS-40404016-Z-2 | 16 | |||||
| 4018-2 | QMNS-40404018-Z-2 | 18 | |||||
| 4020-2 | QMNS-40404020-Z-2 | 20 | |||||
| 2612-1 | STRAIGHT(26) | QMNS-26262612-Z-1 | 26 | 26 | 26 | 12 | 10° |
| 2614-1 | OMNS-26262614-Z-1 | 14 | |||||
| 2616-1 | QMNS-26262616-Z-1 | 16 | |||||
| 2612-2 | OMNS-26262612-Z-2 | 26 | 26 | 26 | 12 | 70° | |
| 2014-2 | QMNS-26262614-Z-2 | 14 | |||||
| 2016-2 | QMNS-26262616-Z-2 | 16 | |||||
| 3518-1 | TRAPEZOID | QMNS-35183518-S-1 | 35 | 18 | 35 | 18 | 10° |
| 3520-1 | OMNS-35183520-S-1 | 20 | |||||
| 3518-2 | OMNS-35183518-S-2 | 35 | 18 | 35 | 18 | 70° | |
| 3520-2 | QMNS-35183520-S-2 | 20 | |||||
| 3518-3 | QMNS-35183518-S-3 | 35 | 18 | 35 | 18 | 110° | |
| 3520-3 | QMNS-35183520-S-3 | 20 | |||||
| 254016 | HOURGLASS | QMNS-254016-T-1 | 25 | / | 40 | 16 | 10° |
| 254018 | QMNS-254018-T-1 | 18 | |||||
| 254020 | OMNS-254020-T-1 | 20 | |||||